Search Results for: G1 Therapeutics Initiates Three Drug
Articles
January 17, 2017
G1 Therapeutics Initiates Three Drug Development Programs January 17, 2017
G1 Therapeutics, Inc., a clinical-stage oncology company, recently announced the expansion of its pipeline of novel cancer therapies with the...
September 18, 2023
Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill Containing Ustekinumab Biosimilar, CT-P43) September 18, 2023
Rani Therapeutics Holdings, Inc. recently announced the initiation of a Phase 1 clinical trial to evaluate the safety and tolerability...
December 15, 2021
BioXcel Therapeutics Initiates Pivotal Phase 3 Program of BXCL501 for Acute Treatment of Agitation in Patients With Alzheimer’s Disease December 15, 2021
BioXcel Therapeutics, Inc. recently announced the initiation of its pivotal Phase 3 program for BXCL501, the company’s proprietary, orally dissolving...
